losartan has been researched along with Epilepsy, Temporal Lobe in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Epilepsy, Temporal Lobe: A localization-related (focal) form of epilepsy characterized by recurrent seizures that arise from foci within the TEMPORAL LOBE, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures (see EPILEPSY, COMPLEX PARTIAL) originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic. (From Adams et al., Principles of Neurology, 6th ed, p321).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Losartan treatment started after onset of SE and continued for 4weeks." | 1.40 | Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy. ( Atanasova, D; Ivanova, NM; Kortenska, L; Lazarov, N; Lozanov, V; Mitreva, R; Pechlivanova, DM; Stoynev, A; Tchekalarova, JD, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tchekalarova, JD | 1 |
| Ivanova, NM | 1 |
| Pechlivanova, DM | 1 |
| Atanasova, D | 1 |
| Lazarov, N | 1 |
| Kortenska, L | 1 |
| Mitreva, R | 1 |
| Lozanov, V | 1 |
| Stoynev, A | 1 |
| Tsai, CY | 1 |
| Chan, JY | 1 |
| Hsu, KS | 1 |
| Chang, AY | 1 |
| Chan, SH | 1 |
2 other studies available for losartan and Epilepsy, Temporal Lobe
| Article | Year |
|---|---|
Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anticonvulsants; Epilepsy, Temporal Lobe; Kainic A | 2014 |
Brain-derived neurotrophic factor ameliorates brain stem cardiovascular dysregulation during experimental temporal lobe status epilepticus.
Topics: Acetophenones; Animals; Antioxidants; Brain Stem; Brain-Derived Neurotrophic Factor; Cardiovascular | 2012 |